Outcomes by clinical and molecular features in children with medulloblastoma treated with risk-adapted therapy: results of an international phase III trial (SJMB03)

DNA methylation-based classification of central nervous system tumours

Capper, D., Jones, D., Sill, M., Hovestadt, V., Schrimpf, D., Sturm, D., Koelsche, C., Sahm, F., Chávez, L., Reuß, D., et al. (2018) · Nature · doi:10.1038/nature26000 · Cited by 3,046 · see citing works

Molecular subgroups of medulloblastoma: the current consensus

Taylor, M. D., Northcott, P. A., Korshunov, A., Remke, M., Cho, Y.-J., Clifford, S. C., Eberhart, C. G., Parsons, D. W., Rutkowski, S., Gajjar, A., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0922-z · Cited by 1,936 · see citing works

Medulloblastoma Comprises Four Distinct Molecular Variants

Northcott, P. A., Korshunov, A., Witt, H., Hielscher, T., Eberhart, C. G., Mack, S. C., Bouffet, É., Clifford, S. C., Hawkins, C. E., French, P. J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4324 · Cited by 1,329 · see citing works

Intertumoral Heterogeneity within Medulloblastoma Subgroups

Cavalli, F. M. G., Remke, M., Rampasek, L., Peacock, J., Shih, D. J. H., Luu, B., Garzia, L., Torchia, J., Nor, C., Morrissy, A. S., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.005 · Cited by 1,219 · see citing works

The whole-genome landscape of medulloblastoma subtypes

Northcott, P. A., Buchhalter, I., Morrissy, A. S., Hovestadt, V., Weischenfeldt, J., Ehrenberger, T., Gröbner, S., Segura-Wang, M., Zichner, T., Rudneva, V. A., et al. (2017) · Nature · doi:10.1038/nature22973 · Cited by 1,112 · see citing works

Phase III Study of Craniospinal Radiation Therapy Followed by Adjuvant Chemotherapy for Newly Diagnosed Average-Risk Medulloblastoma

Packer, R. J., Gajjar, A. J., Vézina, G., Rorke-Adams, L. B., Burger, P. C., Robertson, P. L., Bayer, L. A., Lafond, D. A., Donahue, B. R., Marymont, M. H., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4980 · Cited by 985 · see citing works

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

Gajjar, A. J., Chintagumpala, M., Ashley, D. M., Kellie, S. J., Kun, L. E., Merchant, T. E., Woo, S. Y., Wheeler, G., Ahern, V., Krasin, M. J., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70867-1 · Cited by 951 · see citing works

Subgroup-specific structural variation across 1,000 medulloblastoma genomes

Northcott, P. A., Shih, D. J. H., Peacock, J., Garzia, L., Morrissy, A. S., Zichner, T., Stütz, A. M., Korshunov, A., Reimand, J., Schumacher, S. E., et al. (2012) · Nature · doi:10.1038/nature11327 · Cited by 887 · see citing works

Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations

Rausch, T., Jones, D. T. W., Zapatka, M., Stütz, A. M., Zichner, T., Weischenfeldt, J., Jäger, N., Remke, M., Shih, D., Northcott, P. A., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.013 · Cited by 865 · see citing works

Novel mutations target distinct subgroups of medulloblastoma

Robinson, G. W., Parker, M. D., Kranenburg, T. A., Lu, C., Chen, X. '., Ding, L., Phoenix, T. N., Hedlund, E., Wei, L., Zhu, X., et al. (2012) · Nature · doi:10.1038/nature11213 · Cited by 835 · see citing works

Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition

Kool, M., Jones, D., Jäger, N., Northcott, P. A., Pugh, T. J., Hovestadt, V., Piro, R. M., Esparza, L. A., Markant, S. L., Remke, M., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.004 · Cited by 756 · see citing works

β-Catenin Status Predicts a Favorable Outcome in Childhood Medulloblastoma: The United Kingdom Children's Cancer Study Group Brain Tumour Committee

Ellison, D. W., Onilude, O. E., Lindsey, J. C., Lusher, M. E., Weston, C. L., Taylor, R. E., Pearson, A. D. J., & Clifford, S. C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.5479 · Cited by 434 · see citing works

Resolving medulloblastoma cellular architecture by single-cell genomics

Hovestadt, V., Smith, K. S., Bihannic, L., Filbin, M. G., Shaw, M. L., Baumgartner, A., DeWitt, J. C., Groves, A. P., Mayr, L., Weisman, H. R., et al. (2019) · Nature · doi:10.1038/s41586-019-1434-6 · Cited by 392 · see citing works

Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis

Thompson, E. M., Hielscher, T., Bouffet, É., Remke, M., Luu, B., Gururangan, S., McLendon, R. E., Bigner, D. D., Lipp, E., Perreault, S., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00581-1 · Cited by 367 · see citing works

Hyperfractionated Versus Conventional Radiotherapy Followed by Chemotherapy in Standard-Risk Medulloblastoma: Results From the Randomized Multicenter HIT-SIOP PNET 4 Trial

Lannering, B., Rutkowski, S., Doz, F., Pizer, B. L., Gustafsson, G., Navajas, A., Massimino, M., Reddingius, R. E., Benesch, M., Carrié, C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.8719 · Cited by 332 · see citing works

Cytogenetic Prognostication Within Medulloblastoma Subgroups

Shih, D. J. H., Northcott, P. A., Remke, M., Korshunov, A., Ramaswamy, V., Kool, M., Luu, B., Yao, Y., Wang, X., Dubuc, A. M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.9539 · Cited by 315 · see citing works

Histopathologic grading of medulloblastomas

Eberhart, C. G., Kepner, J. L., Goldthwaite, P. T., Kun, L. E., Duffner, P. K., Friedman, H. S., Strother, D. R., & Burger, P. C. (2002) · Cancer · doi:10.1002/cncr.10189 · Cited by 314 · see citing works

Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes

Sharma, T., Schwalbe, E. C., Williamson, D., Sill, M., Hovestadt, V., Mynarek, M., Rutkowski, S., Robinson, G. W., Gajjar, A., Cavalli, F., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02020-0 · Cited by 310 · see citing works

Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables

Ellison, D. W., Kocak, M., Dalton, J., Megahed, H., Lusher, M. E., Ryan, S. L., Zhao, W., Nicholson, S. L., Taylor, R. E., Bailey, S., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.2810 · Cited by 302 · see citing works

Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays

Hovestadt, V., Remke, M., Kool, M., Pietsch, T., Northcott, P. A., Fischer, R., Cavalli, F. M. G., Ramaswamy, V., Zapatka, M., Reifenberger, G., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1126-5 · Cited by 292 · see citing works

Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma

Gajjar, A., Hernan, R., Kocak, M., Fuller, C., Lee, Y., McKinnon, P. J., Wallace, D., Lau, C., Chintagumpala, M., Ashley, D. M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.032 · Cited by 279 · see citing works

Medulloblastomics revisited: biological and clinical insights from thousands of patients

Hovestadt, V., Ayrault, O., Swartling, F. J., Robinson, G. W., Pfister, S. M., & Northcott, P. A. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-019-0223-8 · Cited by 271 · see citing works

Histopathological and Molecular Prognostic Markers in Medulloblastoma

Eberhart, C. G., Kratz, J., Wang, Y., Summers, K., Stearns, D. S., Cohen, K. J., Dang, C. V., & Burger, P. C. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.5.441 · Cited by 217 · see citing works

Outcome of Children With Metastatic Medulloblastoma Treated With Carboplatin During Craniospinal Radiotherapy: A Children's Oncology Group Phase I/II Study

Jakacki, R. I., Burger, P. C., Zhou, T., Holmes, E. J., Koçak, M., Onar, A., Goldwein, J. L., Mehta, M. P., Packer, R. J., Tarbell, N. J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.2792 · Cited by 216 · see citing works

Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters

von Bueren, A. O., Kortmann, R., von Hoff, K., Friedrich, C., Mynarek, M., Müller, K., Goschzik, T., Mühlen, A. Z., Gerber, N. U., Warmuth‐Metz, M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.2428 · Cited by 188 · see citing works

Germline Elongator mutations in Sonic Hedgehog medulloblastoma

Waszak, S. M., Robinson, G. W., Gudenas, B. L., Smith, K. S., Forget, A., Kojic, M., García-López, J., Hadley, J. L., Hamilton, K. V., Indersie, É., et al. (2020) · Nature · doi:10.1038/s41586-020-2164-5 · Cited by 164 · see citing works

Nodule Formation and Desmoplasia in Medulloblastomas—Defining the Nodular/Desmoplastic Variant and Its Biological Behavior

McManamy, C. S., Pears, J., Weston, C. L., Hanzely, Z., Ironside, J. W., Taylor, R. E., Grundy, R. G., Clifford, S. C., & Ellison, D. W. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00058.x · Cited by 144 · see citing works

Expression of the ErbB-neuregulin signaling network during human cerebellar development: Implications for the biology of medulloblastoma

Gilbertson, R. J., Clifford, S. C., MacMeekin, W., Wright, C., Perry, R., Kelly, P., Pearson, A. D. J., & Lunec, J. (1998) · PubMed · doi:10.25405/ncl.34591221 · Cited by 100 · see citing works

Clinical implications of the 2021 edition of the WHO classification of central nervous system tumours

Horbinski, C., Berger, T., Packer, R. J., & Wen, P. Y. (2022) · Nature Reviews Neurology · doi:10.1038/s41582-022-00679-w · Cited by 312 · see citing works

Serial assessment of measurable residual disease in medulloblastoma liquid biopsies

Liu, A. P. Y., Smith, K. S., Kumar, R., Paul, L., Bihannic, L., Lin, T., Maaß, K. K., Pajtler, K. W., Chintagumpala, M., Su, J. M. F., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.09.012 · Cited by 177 · see citing works

Unified rhombic lip origins of group 3 and group 4 medulloblastoma

Smith, K. S., Bihannic, L., Gudenas, B. L., Haldipur, P., Tao, R., Gao, Q., Li, Y., Aldinger, K. A., Iskusnykh, I. Y., Chizhikov, V. V., et al. (2022) · Nature · doi:10.1038/s41586-022-05208-9 · Cited by 161 · see citing works

Improving quality and quantity of life for childhood cancer survivors globally in the twenty-first century

Ehrhardt, M. J., Krull, K. R., Bhakta, N. H., Liu, Q., Yasui, Y., Robison, L. L., & Hudson, M. M. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00802-w · Cited by 133 · see citing works

Clinical Outcomes and Patient-Matched Molecular Composition of Relapsed Medulloblastoma

Kumar, R., Smith, K. S., Deng, M. Y., Terhune, C., Robinson, G. W., Orr, B. A., Liu, A. P. Y., Lin, T., Billups, C. A., Chintagumpala, M., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01359 · Cited by 86 · see citing works

Medulloblastoma: Current Perspectives and Recent Advances

Choi, J. Y. (2023) · Brain Tumor Research and Treatment · doi:10.14791/btrt.2022.0046 · Cited by 75 · see citing works

Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management

Lazow, M., Palmer, J. D., Fouladi, M., & Salloum, R. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01273-0 · Cited by 58 · see citing works

Update on Cancer Predisposition Syndromes and Surveillance Guidelines for Childhood Brain Tumors

Hansford, J. R., Das, A., McGee, R. B., Nakano, Y., Brzezinski, J. J., Scollon, S., Rednam, S. P., Schienda, J., Michaeli, O., Kim, S. Y., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-4033 · Cited by 51 · see citing works

New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of Pediatric Medulloblastoma

Fang, F. Y., Rosenblum, J. S., Ho, W. S., & Heiss, J. D. (2022) · Cancers · doi:10.3390/cancers14092285 · Cited by 48 · see citing works

Improved Long-Term Survival of Patients with Recurrent Medulloblastoma Treated with a “MEMMAT-like” Metronomic Antiangiogenic Approach

Slavc, I., Mayr, L., Stepien, N. M., Gojo, J., Lippolis, M. A., Azizi, A. A., Chocholous, M., Baumgartner, A., Hedrich, C., Holm, S., et al. (2022) · Cancers · doi:10.3390/cancers14205128 · Cited by 47 · see citing works

Subgroup-Specific Diagnostic, Prognostic, and Predictive Markers Influencing Pediatric Medulloblastoma Treatment

Ray, S., Chaturvedi, N. K., Bhakat, K. K., Rizzino, A., & Mahapatra, S. (2021) · Diagnostics · doi:10.3390/diagnostics12010061 · Cited by 43 · see citing works

Developmental basis of SHH medulloblastoma heterogeneity

Gold, M. P., Ong, W., Masteller, A. M., Ghasemi, D. R., Galindo, J., Park, N. R., Huynh, N. C., Donde, A., Pister, V. I., Saurez, R. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44300-0 · Cited by 36 · see citing works

Primary cilia control translation and the cell cycle in medulloblastomaPreprint

Youn, Y. H., Hou, S., Wu, C., Kawauchi, D., Orr, B. A., Robinson, G. W., Finkelstein, D., Taketo, M. M., Gilbertson, R. J., Roussel, M. F., et al. (2022) · Genes & Development · doi:10.1101/gad.349596.122 · Cited by 36 · see citing works

Adolescents and Young Adults With Cancer: CNS Tumors

Wu, J., Heidelberg, R. E., & Gajjar, A. J. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.01747 · Cited by 35 · see citing works

Association Between Brain Substructure Dose and Cognitive Outcomes in Children With Medulloblastoma Treated on SJMB03: A Step Toward Substructure-Informed Planning

Acharya, S., Guo, Y., Patni, T., Li, Y., Wang, C., Gargone, M., Ashford, J. M., Wilson, L. J., Faught, A., Reddick, W. E., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.01480 · Cited by 36 · see citing works

A spatial cell atlas of neuroblastoma reveals developmental, epigenetic and spatial axis of tumor heterogeneityPreprint

Patel, A. G., Ashenberg, O., Collins, N. B., Segerstolpe, Å., Jiang, S., Slyper, M., Huang, X., Caraccio, C., Jin, H., Sheppard, H., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.07.574538 · Cited by 35 · see citing works

WHO 2021 and beyond: new types, molecular markers and tools for brain tumor classification

Tran, S., & Bielle, F. (2022) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000903 · Cited by 32 · see citing works

Posterior fossa tumors in children: current insights

Formentin, C., Joaquim, A. F., & Ghizoni, E. (2023) · European Journal of Pediatrics · doi:10.1007/s00431-023-05189-5 · Cited by 33 · see citing works

Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions

Lim-Fat, M. J., Bennett, J., Ostrom, Q. T., Touat, M., Franceschi, E., Schulte, J. D., Bindra, R. S., Fangusaro, J., Dhall, G., Nicholson, J. C., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae186 · Cited by 32 · see citing works

Molecular Testing for the World Health Organization Classification of Central Nervous System Tumors

Horbinski, C., Solomon, D. A., Lukas, R. V., Packer, R. J., Brastianos, P. K., Wen, P. Y., Snuderl, M., Berger, M. S., Chang, S. M., Fouladi, M., et al. (2024) · JAMA Oncology · doi:10.1001/jamaoncol.2024.5506 · Cited by 31 · see citing works

Hearing Loss After Radiation and Chemotherapy for CNS and Head-and-Neck Tumors in Children

Keilty, D., Khandwala, M., Liu, Z. A., Papaioannou, V., Bouffet, É., Hodgson, D., Yee, R., Cushing, S., Laperriere, N., Ahmed, S., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00899 · Cited by 30 · see citing works

Molecular classification improves therapeutic options for infants and young children with medulloblastoma

Bagchi, A., Dhanda, S. K., Dunphy, P., Sioson, E., & Robinson, G. W. (2023) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2023.7024 · Cited by 28 · see citing works

High-Dose Chemotherapy in Children with Newly Diagnosed Medulloblastoma

Lafay‐Cousin, L., & Dufour, C. (2022) · Cancers · doi:10.3390/cancers14030837 · Cited by 27 · see citing works

Current studies and future directions for medulloblastoma: A review from the pacific pediatric neuro-oncology consortium (PNOC) disease working group

Cooney, T., Lindsay, H., Leary, S. E. S., & Wechsler‐Reya, R. J. (2022) · Neoplasia · doi:10.1016/j.neo.2022.100861 · Cited by 28 · see citing works

Molecular Subgroup Is the Strongest Predictor of Medulloblastoma Outcome in a Resource-Limited Country

Amayiri, N. Y., Swaidan, M., Ibrahimi, A., Hirmas, N., Musharbash, A. F., Bouffet, É., Al-Hussaini, M. A., & Ramaswamy, V. (2021) · JCO Global Oncology · doi:10.1200/go.21.00127 · Cited by 25 · see citing works

Phase 3 randomized trial of high-dose methotrexate for young children with high-risk embryonal brain tumors: A report from the Children’s Oncology Group

Mazewski, C., Leary, S. E. S., Kang, G., Li, B. K., Kellie, S. J., Hayes, L. L., Shaw, D., Ho, B., Reddy, A. T., Gossett, J. M., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf132 · Cited by 24 · see citing works

Predictors of Cognitive Performance Among Infants Treated for Brain Tumors: Findings From a Multisite, Prospective, Longitudinal Trial

Ali, J. S., Ashford, J. M., Swain, M. A., Harder, L. L., Carlson-Green, B., Miller, J. M., Wallace, J., Kaner, R., Billups, C. A., Onar‐Thomas, A., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01687 · Cited by 24 · see citing works

The Clinical Applications of Liquid Biopsies in Pediatric Brain Tumors: A Systematic Literature Review

Greuter, L., Frank, N. A., Guzman, R. G., & Soleman, J. (2022) · Cancers · doi:10.3390/cancers14112683 · Cited by 24 · see citing works

Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification

Goddard, J., Castle, J., Southworth, E., Fletcher, A., Crosier, S., Martín‐Guerrero, I., García-Ariza, M., Navajas, A., Masliah‐Planchon, J., Bourdeaut, F., et al. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02566-0 · Cited by 25 · see citing works

Pediatric Central Nervous System Cancers, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology

Gajjar, A. J., Mahajan, A., Bale, T., Bowers, D. C., Canan, L., Chi, S. N., Cluster, A. S., Cohen, K. J., Cole, B., Coven, S. L., et al. (2025) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2025.0012 · Cited by 23 · see citing works

Clinical outcome of pediatric medulloblastoma patients with Li–Fraumeni syndrome

Kolodziejczak, A. S., Guerrini‐Rousseau, L., Masliah‐Planchon, J., Ecker, J., Selt, F., Mynarek, M., Obrecht, D., Sill, M., Autry, R. J., Stutheit-Zhao, E., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad114 · Cited by 26 · see citing works

Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastoma

Eckhardt, A., Drexler, R., Schoof, M., Struve, N., Capper, D., Jelgersma, C., Onken, J., Harter, P. N., Weber, K. J., Divé, I., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad197 · Cited by 23 · see citing works

Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumors

Ronsley, R. J., Karvonen, K. A., Cole, B., Paulson, V., Stevens, J., Crotty, E. E., Hauptman, J. S., Lee, A. S., Stasi, S. M., Lockwood, C. M., et al. (2024) · Journal of Neuro-Oncology · doi:10.1007/s11060-024-04645-y · Cited by 22 · see citing works

Local and Systemic Therapy of Recurrent Medulloblastomas in Children and Adolescents: Results of the P-HIT-REZ 2005 Study

Gaab, C., Adolph, J. E., Tippelt, S., Mikasch, R., Obrecht, D., Mynarek, M., Rutkowski, S., Pfister, S. M., Milde, T., Witt, O., et al. (2022) · Cancers · doi:10.3390/cancers14030471 · Cited by 22 · see citing works

Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level

Godbole, S., Voß, H., Gocke, A., Schlumbohm, S., Schumann, Y., Peng, B., Mynarek, M., Rutkowski, S., Dottermusch, M., Dorostkar, M. M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50554-z · Cited by 26 · see citing works

Pediatric pineoblastoma: A pooled outcome study of North American and Australian therapeutic data

Hansford, J. R., Huang, J., Endersby, R., Dodgshun, A. J., Li, B. K., Hwang, E. I., Leary, S. E. S., Gajjar, A. J., von Hoff, K., Wells, O., et al. (2022) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdac056 · Cited by 21 · see citing works

Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts

Mynarek, M., Obrecht, D., Sill, M., Sturm, D., Kloth‐Stachnau, K., Selt, F., Ecker, J., von Hoff, K., Juhnke, B.-O., Goschzik, T., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02522-4 · Cited by 24 · see citing works

A Pilot Study Omitting Radiation in the Treatment of Children with Newly Diagnosed Wnt-Activated Medulloblastoma

Cohen, K. J., Munjapara, V., Aguilera, D. G., Castellino, R. C., Stapleton, S. L., Landi, D. B., Ashley, D. M., Rodríguez, F. J., Hawkins, C. E., Yang, E., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0348 · Cited by 21 · see citing works

The comparison of acute toxicities associated with craniospinal irradiation between photon beam therapy and proton beam therapy in children with brain tumors

Uemura, S., Demizu, Y., Hasegawa, D., Fujikawa, T., Inoue, S., Nishimura, A., Tojyo, R., Nakamura, S., Kozaki, A., Saito, A., et al. (2022) · Cancer Medicine · doi:10.1002/cam4.4553 · Cited by 20 · see citing works

Toxicity and Clinical Results after Proton Therapy for Pediatric Medulloblastoma: A Multi-Centric Retrospective Study

Ruggi, A., Melchionda, F., Sardi, I., Pavone, R., Meneghello, L., Kitanovski, L., Zaletel, L. Z., Farace, P., Zucchelli, M., Scagnet, M., et al. (2022) · Cancers · doi:10.3390/cancers14112747 · Cited by 19 · see citing works

The clinical significance of sub-total surgical resection in childhood medulloblastoma: a multi-cohort analysis of 1100 patients

Keeling, C., Davies, S., Goddard, J., Ramaswamy, V., Schwalbe, E. C., Bailey, S., Hicks, D., & Clifford, S. C. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102469 · Cited by 19 · see citing works

Simultaneous Ultra-Sensitive Detection of Structural and Single Nucleotide Variants Using Multiplex Droplet Digital PCR in Liquid Biopsies from Children with Medulloblastoma

Arthur, C., Jylhä, C., de Ståhl, T. D., Shamikh, A., Sandgren, J., Rosenquist, R., Nordenskjöld, M., Harila‐Saari, A. H., Barbany, G., Sandvik, U., et al. (2023) · Cancers · doi:10.3390/cancers15071972 · Cited by 18 · see citing works

Long-term outcomes and late toxicity of adult medulloblastoma treated with combined modality therapy: A contemporary single-institution experience

Saraf, A., Yock, T. I., Niemierko, A., Oh, K. S., Curry, W. T., Butler, W. E., Forst, D. A., Arrillaga‐Romany, I., Ebb, D. H., Tarbell, N. J., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac126 · Cited by 17 · see citing works

CAR T cell therapy for pediatric central nervous system tumors: a review of the literature and current North American trials

Ronsley, R. J., Bertrand, K. C., Song, E. Z., Timpanaro, A., Choe, M., Tlais, D., Vitanza, N. A., & Park, J. R. (2024) · Cancer and Metastasis Reviews · doi:10.1007/s10555-024-10208-4 · Cited by 17 · see citing works

The Blood-Brain Barrier: Implications for Experimental Cancer Therapeutics

Straehla, J. P., Reardon, D. A., Wen, P. Y., & Agar, N. Y. R. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-040433 · Cited by 16 · see citing works

Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment?

Gatto, L., Franceschi, E., Tosoni, A., Nunno, V. D., Bartolini, S., & Brandes, A. A. (2022) · Cancers · doi:10.3390/cancers14020333 · Cited by 16 · see citing works

Endocrinopathy After Treatment for Medulloblastoma: Results From the SJMB03 Trial of Risk-Adapted Radiation Therapy

Merchant, T. E., Wu, S., Onar‐Thomas, A., Delaney, A., & Gajjar, A. J. (2022) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2022.12.016 · Cited by 15 · see citing works

MRI features of pediatric atypical teratoid rhabdoid tumors and medulloblastomas of the posterior fossa

Wu, H., Wu, C., Lin, S., Wu, C., Chen, H., Chen, Y., Lee, Y., & Chang, F. (2023) · Cancer Medicine · doi:10.1002/cam4.5780 · Cited by 15 · see citing works

Current Strategies for Management of Medulloblastoma

Prados, M. D. (2023) · Diagnostics · doi:10.3390/diagnostics13162622 · Cited by 17 · see citing works

N-of-1 Trials in Pediatric Oncology: From a Population-Based Approach to Personalized Medicine—A Review

Kýr, M., Svobodník, A., Štěpánová, R., & Hejnová, R. (2021) · Cancers · doi:10.3390/cancers13215428 · Cited by 15 · see citing works

Anatomic Neuroimaging Characteristics of Posterior Fossa Type A Ependymoma Subgroups

Sabin, N. D., Hwang, S. N., Klimo, P., Chambwe, N., Tatevossian, R. G., Patni, T., Li, Y., Boop, F. A., Anderson, E., Gajjar, A., et al. (2021) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7322 · Cited by 14 · see citing works

WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go?

Mani, S., Chatterjee, A., Dasgupta, A., Shirsat, N. V., Epari, S., Chinnaswamy, G., & Gupta, T. (2023) · Oncotarget · doi:10.18632/oncotarget.28360 · Cited by 14 · see citing works

Evolution of Systemic Therapy in Medulloblastoma Including Irradiation-Sparing Approaches

Mushtaq, N., Ain, R. U., Hamid, S. A., & Bouffet, É. (2023) · Diagnostics · doi:10.3390/diagnostics13243680 · Cited by 13 · see citing works

OLIG2 mediates a rare targetable stem cell fate transition in sonic hedgehog medulloblastoma

Desai, K., Wanggou, S., Luis, E., Whetstone, H., Yu, C., Vanner, R. J., Selvadurai, H. J., Lee, L., Vijay, J., Jaramillo, J. E., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-54858-y · Cited by 15 · see citing works

Children's Oncology Group's 2023 blueprint for research: Central nervous system tumors

Leary, S. E. S., Onar‐Thomas, A., Fangusaro, J., Gottardo, N. G., Cohen, K. J., Smith, A., Huang, A., Haas-Kogan, D. A., & Fouladi, M. (2023) · Pediatric Blood & Cancer · doi:10.1002/pbc.30600 · Cited by 13 · see citing works

Advancing medulloblastoma therapy: strategies and survival insights

Pan, Z., Bao, J., & Wei, S. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01648-5 · Cited by 12 · see citing works

Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma

Pribnow, A. K., Jonchère, B., Liu, J., Smith, K. S., Campagne, O., Xu, K., Robinson, S., Patel, Y. T., Onar‐Thomas, A., Wu, G., et al. (2022) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0598 · Cited by 12 · see citing works

From sorting to sequencing in the molecular era: the evolution of the cancer stem cell model in medulloblastoma

Werbowetski‐Ogilvie, T. E. (2021) · FEBS Journal · doi:10.1111/febs.15817 · Cited by 13 · see citing works

Characteristics of the blood–brain barrier in pediatric brain tumors

Gao, Q., Song, D., Xu, D., Chai, X., & Ge, M. (2025) · Frontiers in Pediatrics · doi:10.3389/fped.2025.1646641 · Cited by 11 · see citing works

MYC overexpression and SMARCA4 loss cooperate to drive medulloblastoma formation in mice

Göbel, C., Godbole, S., Schoof, M., Holdhof, D., Kresbach, C., Loose, C., Neumann, J. E., & Schüller, U. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01654-2 · Cited by 11 · see citing works

Gene context drift identifies drug targets to mitigate cancer treatment resistance

Jassim, A., Nimmervoll, B. V., Terranova, S., Nathan, E., Hu, L., Taylor, J., Masih, K. E., Ruff, L., Duarte, M., Cooper, E. A., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.06.005 · Cited by 11 · see citing works

Ultra-low-input cell-free DNA sequencing for tumor detection and characterization in a real-world pediatric brain tumor cohort

Fischer, T. T., Maaß, K. K., Puranachot, P., Mieskolainen, M., Sill, M., Schad, P. S., Volz, S., Rosing, F., Wedig, T., Schwarz, N., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02024-w · Cited by 11 · see citing works

Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells

Zeuner, S., Vollmer, J., Sigaud, R., Oppermann, S., Peterziel, H., ElHarouni, D., Oehme, I., Witt, O., Milde, T., & Ecker, J. (2024) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04526-w · Cited by 11 · see citing works

Only the beginning: 50 years of progress toward curing childhood cancer

Gore, L., & O'Brien, M. M. (2024) · Cell · doi:10.1016/j.cell.2024.02.039 · Cited by 10 · see citing works

Outcomes of pediatric medulloblastoma in low- and middle-income countries: A retrospective analysis of 335 cases from 8 countries

Díaz-Coronado, R., Alcasabas, A. P., Baticulon, R. E., Hamid, S. A., Omran, N., Sharafeldin, H. A., Pineda, E., del Campo, R. M. N.-M., Foo, J. C., Ganesan, D., et al. (2025) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaf086 · Cited by 10 · see citing works

Medulloblastoma: prognostic subtypes revealed

Sidaway, P. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00478-0 · Cited by 10 · see citing works

Cerebellar Mutism Syndrome and Dentato-Thalamo-Cortical Tract Disruption in Diffusion Tractography Following Surgery for Medulloblastoma

Ji, Q., McAfee, S. S., Scoggins, M., Holtrop, J. L., Glass, J. O., Yuan, X., Liang, J., Li, Y., Chiang, J., Orr, B. A., et al. (2024) · Radiology · doi:10.1148/radiol.232521 · Cited by 10 · see citing works

Hypogonadism After Treatment for Medulloblastoma: Results From the SJMB03 Trial of Risk-Adapted Radiation Therapy

Merchant, T. E., Wu, S., Onar‐Thomas, A., Gajjar, A. J., & Delaney, A. (2023) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2023.01.001 · Cited by 9 · see citing works

Cross-species analysis of SHH medulloblastoma models reveals significant inhibitory effects of trametinib on tumor progression

Borlase, S., DeCarlo, A., Coudière-Morrison, L., Liang, L., Porter, C. J., Ramaswamy, V., & Werbowetski‐Ogilvie, T. E. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01646-0 · Cited by 8 · see citing works

Synergy of retinoic acid and BH3 mimetics in MYC(N)-driven embryonal nervous system tumours

Seiboldt, T., Zeiser, C., Nguyen, D., Çelikyürekli, S., Herter, S., Najafi, S., Stroh-Dege, A., Meulenbroeks, C., Mack, N. L., Salem-Altintas, R., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02740-5 · Cited by 9 · see citing works

Advancing Medulloblastoma Therapy in Pediatrics: Integrative Molecular Classification and Emerging Treatments

Kim, D. T., Uloho-Okundaye, M., Frederico, S. C., Guru, S., Kim, M. J., & Chang, S. D. (2025) · Brain Sciences · doi:10.3390/brainsci15080896 · Cited by 10 · see citing works

Single-cell multi-omics identifies metabolism-linked epigenetic reprogramming as a driver of therapy-resistant medulloblastoma

Veo, B. L., Wang, D., DeSisto, J. A., Pierce, A. M., Brunt, B., Bompada, P., Donson, A. M., Goodspeed, A. E., Smart, K., Foreman, N. K., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65466-9 · Cited by 11 · see citing works

Review of the impact of molecular analysis on the therapy of medulloblastoma

Sarvode, S., & Gajjar, A. J. (2023) · Pediatric Hematology Oncology Journal · doi:10.1016/j.phoj.2023.05.001 · Cited by 9 · see citing works

Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study

Fukuoka, K., Kurihara, J., Shofuda, T., Kagawa, N., Yamasaki, K., Ando, R., Ishida, J., Kanamori, M., Kawamura, A., Park, Y.-S., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01652-4 · Cited by 9 · see citing works

Overview and recent advances in the targeting of medulloblastoma cancer stem cells

Paul, M. R., & Zage, P. E. (2021) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2021.1932472 · Cited by 10 · see citing works

Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer

Forrest, S. J., Gupta, H. V., Ward, A., Li, Y. Y., Doan, D., Al‐Ibraheemi, A., Alexandrescu, S., Bandopadhayay, P., Shusterman, S., Mullen, E. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49944-0 · Cited by 8 · see citing works

An integrated analysis of three medulloblastoma clinical trials refines risk-stratification approaches for reducing toxicity and improving survival

Smith, K. S., Dhanda, S. K., Billups, C. A., Sioson, E., Lu, C., Peraza, A. Z., Gangwani, K., Li, Y., Li, Q., Lin, T., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf250 · Cited by 8 · see citing works

How do we approach the management of medulloblastoma in young children?

Lafay‐Cousin, L., Baroni, L., Ramaswamy, V., & Bouffet, É. (2022) · Pediatric Blood & Cancer · doi:10.1002/pbc.29838 · Cited by 9 · see citing works

Postoperative radiotherapy timing, molecular subgroups and treatment outcomes of Thai pediatric patients with medulloblastoma

Jaruthien, T., Nantavithya, C., Santisukwongchote, S., Shuangshoti, S., Techavichit, P., Sosothikul, D., Amornfa, J., & Shotelersuk, K. (2023) · PLoS ONE · doi:10.1371/journal.pone.0271778 · Cited by 8 · see citing works

Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups

Tonn, S., Korshunov, A., Obrecht, D., Sill, M., Spohn, M., von Hoff, K., Milde, T., Pietsch, T., Goschzik, T., Bison, B., et al. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad027 · Cited by 8 · see citing works

Optical genome mapping identifies a novel pediatric embryonal tumor with a ZNF532::NUTM1 fusion

Bornhorst, M., Eze, A., Bhattacharya, S., Putnam, E., Almira-Suarez, M. I., Rossi, C., Kambhampati, M., Almalvez, M., Barseghyan, M., Risco, N. D., et al. (2023) · The Journal of Pathology · doi:10.1002/path.6085 · Cited by 8 · see citing works

Clinical, Histological, and Molecular Prognostic Factors in Childhood Medulloblastoma: Where Do We Stand?

Ntenti, C., Lallas, K., & Papazisis, G. (2023) · Diagnostics · doi:10.3390/diagnostics13111915 · Cited by 8 · see citing works

Verschlimmbesserung: Craniospinal Radiotherapy Is Essential in WNT Medulloblastoma Patients

Gottardo, N. G., & Gajjar, A. J. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-2331 · Cited by 8 · see citing works

Normal tissue complication probability modeling to guide individual treatment planning in pediatric cranial proton and photon radiotherapy

Dell’Oro, M., Wilson, P., Short, M., Hua, C., Merchant, T. E., & Bezak, E. (2021) · Medical Physics · doi:10.1002/mp.15360 · Cited by 8 · see citing works

Temporal changes in childhood cancer incidence and survival by stage at diagnosis in Australia, 2000–2017

Youlden, D. R., Baade, P. D., Frazier, A. L., Gupta, S., Gottardo, N. G., Moore, A. S., & Aitken, J. F. (2023) · Acta Oncologica · doi:10.1080/0284186x.2023.2251668 · Cited by 7 · see citing works

SMARCA4 Loss and Mutated β-Catenin Induce Proliferative Lesions in the Murine Embryonic Cerebellum

Göbel, C., Schoof, M., Holdhof, D., Spohn, M., & Schüller, U. (2024) · Journal of Neuroscience · doi:10.1523/jneurosci.1605-23.2024 · Cited by 7 · see citing works

Long-term outcome of the Milano-hyperfractionated accelerated radiotherapy strategy for high-risk medulloblastoma, including the impact of molecular subtype

Massimino, M., Barretta, F., Dossena, C., Minasi, S., Buttarelli, F. R., Biassoni, V., Oriani, M., Schiavello, E., Ficorilli, M., Nigro, O., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae189 · Cited by 7 · see citing works

Treatment barriers and clinical outcome of children with medulloblastoma in China: a report from the Chinese Children’s Cancer Group (CCCG)

Liu, A. P. Y., Zhen, Z., Yang, Q., Yuan, X., Ma, X., Chen, J., Wang, J., Yang, L., Guo, H., Jiang, L., et al. (2021) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdab134 · Cited by 7 · see citing works

Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional study

Lucas, J. T., Tinkle, C. L., Huang, J., Onar‐Thomas, A., Srinivasan, S., Tumlin, P., Becksfort, J. B., Klimo, P. D., Boop, F. A., Robinson, G. W., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab284 · Cited by 7 · see citing works

Questions and answers in the management of children with medulloblastoma over the time. How did we get here? A systematic review

Osuna‐Marco, M. P., Martín‐López, L. I., Tejera, Á. M., & López‐Ibor, B. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1229853 · Cited by 7 · see citing works

Targeting synthetic lethality between non-homologous end joining and radiation in very-high-risk medulloblastoma

DeCarlo, A., MacLeod, G. D. A. H., da Silva, C. F., Shen, L., Povilaikaite, J., Deane, M., Aragao, L., Sie, M., Termini, D., Magee, J., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102202 · Cited by 6 · see citing works

Innovative machine learning approach for liver fibrosis and disease severity evaluation in MAFLD patients using MRI fat content analysis

Hou, M., Zhu, Y., Zhou, H., Zhou, S., Zhang, J., Zhang, Y., & Liu, X. (2025) · Clinical and Experimental Medicine · doi:10.1007/s10238-025-01818-5 · Cited by 6 · see citing works

WNT‐activated, MYC ‐amplified medulloblastoma displaying intratumoural heterogeneity

Green, S. T., Hoover, T., Doss, D., Davidow, K. A., Walter, A. W., Cottrell, C. E., & Mahapatra, S. (2023) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12945 · Cited by 4 · see citing works

Medulloblastoma Molecular Subgrouping and Outcomes Data of a Single Center From a Low‐ and Middle‐Income Country

Mushtaq, N., Bashir, F., Zahid, S., Riaz, Q., Javed, G., Tariq, M., Qureshi, B. M., Hilal, K., Ramaswamy, V., Hawkins, C. E., et al. (2025) · Pediatric Blood & Cancer · doi:10.1002/pbc.31555 · Cited by 6 · see citing works

Therapeutic radiation drives leptomeningeal dissemination of medulloblastoma through an innate immune process

Nör, C., Kharas, K., Rasnitsyn, A., Vladoiu, M. C., Cho, N. W., Young, J. S., Nör, F., Mankahla, N., Haapasalo, J. A., Nordfors, K., et al. (2025) · Developmental Cell · doi:10.1016/j.devcel.2025.06.016 · Cited by 7 · see citing works

Effects of different molecular subtypes and tumor biology on the prognosis of medulloblastoma

Aras, Y., Dölen, D., Çelik, A. İ., Kayhan, G. K., Kebudi, R., Ünverengil, G., Sabancı, P. A., & İzgi, N. (2021) · Child s Nervous System · doi:10.1007/s00381-021-05350-1 · Cited by 6 · see citing works

The Site of Origin of Medulloblastoma: Surgical Observations Correlated to Molecular Groups

Ciobanu-Caraus, O., Czech, T., Peyrl, A., Haberler, C., Kasprian, G. J., Furtner, J., Kool, M., Sill, M., Frischer, J. M., Cho, A., et al. (2023) · Cancers · doi:10.3390/cancers15194877 · Cited by 6 · see citing works

Clinico-Radiological Outcomes in WNT-Subgroup Medulloblastoma

Mani, S., Chatterjee, A., Dasgupta, A., Shirsat, N. V., Pawar, A., Epari, S., Sahay, A., Sahu, A., Moiyadi, A. V., Prasad, M., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14040358 · Cited by 5 · see citing works

Radiotherapy for Recurrent Medulloblastoma in Children and Adolescents: Survival after Re-Irradiation and First-Time Irradiation

Adolph, J. E., Fleischhack, G., Tschirner, S., Rink, L., Dittes, C., Mikasch, R., Dammann, P. R., Mynarek, M., Obrecht, D., Rutkowski, S., et al. (2024) · Cancers · doi:10.3390/cancers16111955 · Cited by 5 · see citing works

Building pediatric neuro-oncology capacity in LMICs through multidisciplinary education and collaboration: a mixed-methods analysis

Berg, F., Bryan, G., Andujar, A., Graetz, D. E., Galindo, C. R., Qaddoumi, I. A., & Moreira, D. C. (2025) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaf153 · Cited by 5 · see citing works

Medulloblastoma: prognostic subtypes revealed

Sidaway, P. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00478-0 · Cited by 10 · see citing works

An integrated analysis of three medulloblastoma clinical trials refines risk-stratification approaches for reducing toxicity and improving survival

Smith, K. S., Dhanda, S. K., Billups, C. A., Sioson, E., Lu, C., Peraza, A. Z., Gangwani, K., Li, Y., Li, Q., Lin, T., et al. (2025) · Neuro-Oncology · doi:10.1093/neuonc/noaf250 · Cited by 8 · see citing works

MEDB-69. Clinical and molecular meta-analysis of three major medulloblastoma clinical trials (ACNS0331, SJMB03, ACNS0332) uncovers novel strategies to improve risk-stratified therapy

Smith, K. S., Billups, C. A., Dhanda, S. K., Bihannic, L., Vasilyeva, A., Li, Y., Michalski, J. M., Olsen, J. M., Leary, S. E. S., Fouladi, M., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac079.443 · Cited by 1 · see citing works

MEDU-03. MEDULLOBLASTOMA GENOMIC SUBGROUP-SPECIFIC OUTCOMES IN IRRADIATED CHILDREN ABOVE 3 YEARS TREATED AT KING FAHAD MEDICAL CITY (KFMC)

Alharbi, M., Mobarak, N., Mosleh, O., & Abedalthagafi, M. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox083.154 · Cited by 1 · see citing works

Treatment outcomes in standard-risk medulloblastoma patients: the role of molecular genetic stratifications

Flegontov, A., Druy, A. E., Protsvetkina, A. V., Zaytseva, M., Гегелия, Н. В., Petrova, V., Сенченко, М. А., Tarakanova, A. V., Sanakoeva, A. V., Artyomov, A. V., et al. (2025) · Pediatric Hematology/Oncology and Immunopathology · doi:10.24287/j.993